Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Recruiting · NCT05447923 · Interventional (participants receive a specific treatment) · Lead sponsor: Mayo Clinic
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.
Who can take part
Inclusion criteria
- Age 45 years of age or older
- No prior history of colorectal cancer or colon polyps
- No first-degree family history of colorectal cancer who were diagnosed under age 60
- No current gastrointestinal (GI) or rectal symptoms (such as rectal bleeding)
- Have not undergone a colonoscopy in the last 5 years
- Have not had a fecal immunochemical test (FIT) test within the last year
- Participants that attend 4 predominantly African American churches within the Phoenix Community and extend the study opportunity as feasible to other underserved communities in the Phoenix Metro area
Where it is running
1 location listed across 1 US state.
- Mayo Clinic in Arizona - Scottsdale, Arizona, United States